LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and a premier global developer of digital health solutions, is pleased to unveil the agenda for the company’s Investor Day.
The event will take place on Tuesday, November 11, 2025 from 9:00 a.m. to 2:30 p.m. Eastern Standard Time at the Nasdaq MarketSite in New York City. In-person attendance is by invitation only and investors can request such consideration by emailing This email address is being protected from spambots. You need JavaScript enabled to view it.. Those unable to participate onsite can view a live webcast at https://edge.media-server.com/mmc/p/rz6bqgzd/ or see an archived replay of the event in the Investor Relations section of RadNet’s website.
Titled “On the Leading Edge of Healthcare: Advancing Imaging Through Innovation and Technology,” the Investor Day will feature presentations from select RadNet senior executives and clinical leaders who will share the company’s current and longer-term strategic priorities, market opportunities and innovation roadmap.
The agenda is as follows:
In-person attendees will have the exclusive opportunity to engage with RadNet’s leadership, talk with clinical and research experts and view the following demonstrations of RadNet’s DeepHealth cloud-native AI products:
About RadNet, Inc.
RadNet, Inc. is a leading provider of outpatient diagnostic imaging services in the United States, with a network of 405 owned and/or operated imaging centers. The company’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. For more information, visit www.radnet.com.
Contact:
RadNet, Inc.
Mark Stolper
Executive Vice President and Chief Financial Officer
310-445-2928
Or
Jane Mazur
Senior Vice President, Corporate Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Relations:
Addo IR
This email address is being protected from spambots. You need JavaScript enabled to view it.

| Last Trade: | US$78.31 |
| Daily Change: | -0.60 -0.76 |
| Daily Volume: | 884,684 |
| Market Cap: | US$6.040B |
November 05, 2025 October 17, 2025 September 26, 2025 September 08, 2025 | |

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load